
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis—A Survey-Based Study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B2FC925F8D433AB2FC003DC42633.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="diagno">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Diagnostics">
<meta name="citation_title" content="Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis—A Survey-Based Study">
<meta name="citation_author" content="Claudiu Stan">
<meta name="citation_author_institution" content="Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania">
<meta name="citation_author_institution" content="Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)">
<meta name="citation_author" content="Raluca Mititelu">
<meta name="citation_author_institution" content="Department of Nuclear Medicine, Carol Davila Central University Emergency Military Hospital, 010825 Bucharest, Romania; ralunuclear@yahoo.com">
<meta name="citation_author" content="Robert Daniel Adam">
<meta name="citation_author_institution" content="Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)">
<meta name="citation_author_institution" content="Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania">
<meta name="citation_author" content="Ruxandra Jurcuţ">
<meta name="citation_author_institution" content="Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)">
<meta name="citation_author_institution" content="Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania">
<meta name="citation_publication_date" content="2022 Feb 21">
<meta name="citation_volume" content="12">
<meta name="citation_issue" content="2">
<meta name="citation_firstpage" content="556">
<meta name="citation_doi" content="10.3390/diagnostics12020556">
<meta name="citation_pmid" content="35204645">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/pdf/diagnostics-12-00556.pdf">
<meta name="description" content="Amyloidosis is a heterogeneous group of diseases caused by the extracellular deposition of amyloid insoluble fibrils in multiple organs, resulting in various clinical manifestations. Cardiac amyloidosis (CA) occurs mainly in primary light-chain (AL) ...">
<meta name="og:title" content="Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis—A Survey-Based Study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Amyloidosis is a heterogeneous group of diseases caused by the extracellular deposition of amyloid insoluble fibrils in multiple organs, resulting in various clinical manifestations. Cardiac amyloidosis (CA) occurs mainly in primary light-chain (AL) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8870760">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/diagnostics12020556"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/diagnostics-12-00556.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8870760%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8870760/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8870760/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-diagno.png" alt="Diagnostics logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Diagnostics" title="Link to Diagnostics" shape="default" href="http://www.mdpi.com/journal/diagnostics" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Diagnostics (Basel)</button></div>. 2022 Feb 21;12(2):556. doi: <a href="https://doi.org/10.3390/diagnostics12020556" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/diagnostics12020556</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Diagnostics%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diagnostics%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Diagnostics%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Diagnostics%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis—A Survey-Based Study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stan%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Claudiu Stan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Claudiu Stan</span></h3>
<div class="p">
<sup>1</sup>Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania</div>
<div class="p">
<sup>2</sup>Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stan%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudiu Stan</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mititelu%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Raluca Mititelu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Raluca Mititelu</span></h3>
<div class="p">
<sup>3</sup>Department of Nuclear Medicine, Carol Davila Central University Emergency Military Hospital, 010825 Bucharest, Romania; ralunuclear@yahoo.com</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mititelu%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Raluca Mititelu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adam%20RD%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Robert Daniel Adam</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Robert Daniel Adam</span></h3>
<div class="p">
<sup>2</sup>Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div class="p">
<sup>4</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adam%20RD%22%5BAuthor%5D" class="usa-link"><span class="name western">Robert Daniel Adam</span></a>
</div>
</div>
<sup>2,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jurcu%C5%A3%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ruxandra Jurcuţ</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ruxandra Jurcuţ</span></h3>
<div class="p">
<sup>2</sup>Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div class="p">
<sup>4</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jurcu%C5%A3%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruxandra Jurcuţ</span></a>
</div>
</div>
<sup>2,</sup><sup>4</sup>
</div>
<div class="cg p">Editor: <span class="name western">Andrea D Annoni</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-diagnostics-12-00556">
<sup>1</sup>Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania</div>
<div id="af2-diagnostics-12-00556">
<sup>2</sup>Department of Cardiothoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania; robert.adam@drd.umfcd.ro (R.D.A.); ruxandra.jurcut@umfcd.ro (R.J.)</div>
<div id="af3-diagnostics-12-00556">
<sup>3</sup>Department of Nuclear Medicine, Carol Davila Central University Emergency Military Hospital, 010825 Bucharest, Romania; ralunuclear@yahoo.com</div>
<div id="af4-diagnostics-12-00556">
<sup>4</sup>Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania</div>
<div class="author-notes p"><div class="fn" id="c1-diagnostics-12-00556">
<sup>*</sup><p class="display-inline">Correspondence: <span>claudiu.stan@drd.umfcd.ro</span>; Tel./Fax: +40-213-172-194</p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Andrea D Annoni</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Dec 27; Accepted 2022 Feb 18; Collection date 2022 Feb.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2022 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8870760  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35204645/" class="usa-link">35204645</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Amyloidosis is a heterogeneous group of diseases caused by the extracellular deposition of amyloid insoluble fibrils in multiple organs, resulting in various clinical manifestations. Cardiac amyloidosis (CA) occurs mainly in primary light-chain (AL) amyloidosis, hereditary transthyretin (ATTRv) amyloidosis and senile or wild-type transthyretin (ATTRwt) amyloidosis. Knowing that myocardial uptake at bone scintigraphy is an essential step in the ATTR-CA diagnostic algorithm, the level of awareness among nuclear medicine physicians (NMPs) using bone tracer scintigraphy is of great importance. The objective of the study was to evaluate NMPs’ awareness of scintigraphy with bisphosphonates for the detection of CA. We conducted an online survey among NMPs from Romania to assess their current awareness and state of knowledge of nuclear techniques used in CA. Among the total 65 Romanian NMPs, 35 (53%) responded to this questionnaire. Approximately three-quarters of participants (74%) found a diffuse accumulation of bisphosphonates in the heart on scintigraphy performed for bone pathology as an incidental discovery. Detection of myocardial uptake of 99mTc-labeled bisphosphonates on scintigraphy suggests CA-AL for 3% of participants and for 9% of respondents, the appearance is of uncertain cardiac amyloidosis, while 5% of participants observed cardiac uptake but did not report it as CA. Even if more than half of those who responded to this survey (54%) found abnormal cardiac uptake and interpreted it as CA-ATTR, only 14% contacted the referring physician to draw attention to the incidental discovery to refer the patient to a specialist in rare genetic cardiomyopathy. Regarding the knowledge about the categories of bisphosphonates recommended in the diagnosis of CA-ATTR, 54% answered inadequately that methylene diphosphonate (MDP) could be used. Romanian nuclear physicians are partially familiar with CA diagnosis by scintigraphy, but its diagnostic potential and standardization, recommended radiotracers and acquisition times and interpretation algorithms are known in varying proportions. Therefore, there is a need to enhance knowledge through continuing medical education programs in order to standardize the protocols for the acquisition, processing and interpretation of bisphosphonate scintigraphy for the detection of cardiac ATTR amyloidosis. </p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> amyloidosis, nuclear medicine, awareness, survey, ATTR</p></section></section><section id="sec1-diagnostics-12-00556"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Amyloidosis is a disease produced by the deposition of specific amyloid fibril proteins in different organs and tissues. Amyloid is recognized microscopically by its amorphous structure, an affinity for the Congo red dye and its increased birefringence under polarized light. According to the International Society of Amyloidosis Nomenclature Committee, the number of mature proteins responsible for amyloidosis is 18 proteins for systemic amyloidosis and 22 for localized forms; even some proteins can appear as systemic and localized amyloid deposits [<a href="#B1-diagnostics-12-00556" class="usa-link" aria-describedby="B1-diagnostics-12-00556">1</a>]. </p>
<p>Of the 36 human amyloid fibrillar proteins currently discovered, only 9 can involve the myocardium and cause significant heart disease. However, more than 98% of amyloid cardiomyopathies are due to light chain monoclonal immunoglobulins (AL) and fibrilar transthyretin (ATTR). Other types of cardiac involvement (AApoAI, AApoAII, AApoAIV, Aβ2M, AFib, AGel) and cardiac amyloidosis secondary to chronic inflammatory and infectious diseases (AA) are very rare in medical practice [<a href="#B1-diagnostics-12-00556" class="usa-link" aria-describedby="B1-diagnostics-12-00556">1</a>,<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. </p>
<p>ATTR cardiac amyloidosis is the second most common form of CA after cardiac involvement in AL amyloidosis. The two types of ATTR cardiac amyloidosis (ATTR-CA) are the wild type (ATTRwt-CA), previously called senile, and the hereditary or variant form (ATTRv-CA). Having more than 130 genetic variants detected, ATTRv-CA is a rare autosomal dominant condition caused by mutations in the transthyretin gene [<a href="#B3-diagnostics-12-00556" class="usa-link" aria-describedby="B3-diagnostics-12-00556">3</a>]. ATTRwt amyloidosis has 100% heart involvement, with a median survival from diagnosis of 57 months, while in ATTRv amyloidosis, the frequency of cardiac localization varies between 30–100%, and the median survival is 31 months, depending on the mutation [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. The usual extracardiac signs in ATTRwt amyloidosis are bilateral carpal tunnel syndrome, lumbar spinal stenosis, and biceps tendon rupture. Other extracardiac signs in ATTRv amyloidosis depend on the tissue location of amyloid fibrillar proteins: polyneuropathy, orthostatic hypotension, vitreous opacities, and gastrointestinal manifestations [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. Recent studies have shown an increased prevalence of up to 15% of ATTRwt cardiac amyloidosis in older adults with heart failure with preserved ejection fraction (HFpEF) or in severe aortic stenosis [<a href="#B4-diagnostics-12-00556" class="usa-link" aria-describedby="B4-diagnostics-12-00556">4</a>,<a href="#B5-diagnostics-12-00556" class="usa-link" aria-describedby="B5-diagnostics-12-00556">5</a>,<a href="#B6-diagnostics-12-00556" class="usa-link" aria-describedby="B6-diagnostics-12-00556">6</a>]. </p>
<p>The diagnostic criteria for CA are divided into invasive and noninvasive diagnostic techniques. In the presence of amyloid fibrillar proteins identified on endomyocardial biopsy samples using Congo red staining, cardiac amyloidosis can be confirmed. Identification of the type of amyloid is performed in clinical practice by immunohistochemistry or immunoelectron microscopy. Along with the characteristic features from echocardiography or cardiac magnetic resonance imaging, the presence of amyloid deposits at extracardiac biopsy completes the invasive diagnosis of cardiac amyloidosis [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. However, the diagnostic yield of fat aspirate for amyloidosis is much lower for ATTRwt (15%) and ATTRv (50%) than for AL amyloidosis [<a href="#B7-diagnostics-12-00556" class="usa-link" aria-describedby="B7-diagnostics-12-00556">7</a>]. </p>
<p>While invasive criteria apply to all cases of cardiac amyloidosis, extracardiac biopsy sensitivity is low for ATTR, and endomyocardial biopsy has a high-risk profile. The noninvasive criteria for the diagnosis of ATTR-CA consist of positive bisphosphonate scintigraphy and absence of monoclonal dyscrasia, along with typical findings on echocardiography and CMR [<a href="#B8-diagnostics-12-00556" class="usa-link" aria-describedby="B8-diagnostics-12-00556">8</a>]. A Perugini visual score of 2 or 3, corresponding to a degree of myocardial uptake, on bisphosphonate scintigraphy with 99mTc-pyrophosphate (PYP), 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) or 99mTc-hydroxymethylene diphosphonate (HMDP), has already been validated by multiple clinical trials for the positive diagnosis of ATTR-CA [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>,<a href="#B10-diagnostics-12-00556" class="usa-link" aria-describedby="B10-diagnostics-12-00556">10</a>]. Plasma cell proliferative diseases can be ruled out with a sensitivity of 100% by the absence of fibrillar protein precursors in serum and urine using the following tests: serum and urinary protein electrophoresis with immunofixation (sIFE, uIFE) and detection of serum-free, light chains with kappa/lambda ratio (sFLC κ/λ) [<a href="#B11-diagnostics-12-00556" class="usa-link" aria-describedby="B11-diagnostics-12-00556">11</a>]. </p>
<p>With the recent indication for TTR stabilizers (tafamidis) as effective therapies for reducing ATTR-CA all-cause mortality and cardiovascular-related hospitalizations [<a href="#B7-diagnostics-12-00556" class="usa-link" aria-describedby="B7-diagnostics-12-00556">7</a>,<a href="#B12-diagnostics-12-00556" class="usa-link" aria-describedby="B12-diagnostics-12-00556">12</a>], an early diagnosis is essential for instituting the earliest effective therapy, casting the importance of awareness of diagnostic methods.</p>
<p>We, therefore, conducted the current survey among nuclear medicine physicians in Romania to evaluate their awareness of the diagnostic features and forms of cardiac amyloidosis and how it is reflected in their daily medical practice.</p></section><section id="sec2-diagnostics-12-00556"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<p>An online survey was conducted among nuclear medicine physicians (NMPs) from all hospitals and health centers in Romania during a 4-month interval between 1 October 2020 and 31 January 2021. It consisted of 31 questions with single or multiple answers developed by the authors, which included a general part (working place, level of medical expertise in general and nuclear cardiology in particular) and a special section regarding diagnostic features in CA. </p>
<p>The questionnaire was developed based on the authors’ experience, who are part of a multidisciplinary diagnostic team for CA in an Expert Center for Cardiac Rare Disease and considering international consensus and up-to-date literature, as well as based on recommendations for surveys [<a href="#B13-diagnostics-12-00556" class="usa-link" aria-describedby="B13-diagnostics-12-00556">13</a>,<a href="#B14-diagnostics-12-00556" class="usa-link" aria-describedby="B14-diagnostics-12-00556">14</a>,<a href="#B15-diagnostics-12-00556" class="usa-link" aria-describedby="B15-diagnostics-12-00556">15</a>]. </p>
<p>The complete copy of the online questionnaire is available on “<a href="#app1-diagnostics-12-00556" class="usa-link">Supplementary Materials</a>”. The survey was uploaded to a platform dedicated to online questionnaires and was distributed to NMPs who were or were not members of the Romanian Society of Nuclear Medicine and Molecular Imaging (SRMNIM) by e-mail or messaging applications. </p>
<p>The specialty of nuclear medicine in Romania includes about 65 NMPs, of which 15 are in different training stages. In total, 35 NMPs (53%) answered the questionnaire. All participants could answer the questionnaire only once. Participation in the questionnaire was anonymous and voluntary, and participants were informed that the authors planned to publish the results, so ethical approval was not required.</p>
<p>After the end of the 4-month period, the data were collected, and the results were calculated as a percentage of the total number of responses.</p></section><section id="sec3-diagnostics-12-00556"><h2 class="pmc_sec_title">3. Results</h2>
<section id="sec3dot1-diagnostics-12-00556"><h3 class="pmc_sec_title">3.1. Survey Participants</h3>
<p>Of the 35 survey participants, 85% practiced in the 3 largest Romanian university centers: 45% in the country’s capital (Bucharest), 28% from Iasi and 11% from Cluj. Regarding training, out of the three levels of training in Romania, 62% were senior NMPs (highest level), 22% were specialized NMPs (intermediate level), and 14% were NMPs in training. This distribution is like the career levels distribution of the members of the National Society for Nuclear Medicine in Romania. Of the 35 participants who responded to this survey, 80% work in a university hospital. Moreover, the work environment was reported as a public hospital (82%), private medical center (only 17%), and both in a public hospital as well as in a private one (25%). Currently, each month, the number of patients investigated by conventional nuclear medicine techniques (e.g., bone scintigraphy BS, myocardial perfusion scintigraphy and so on) exceeds 150 (only for 11% of respondents), falling within the range of 101–150 (for 17%), between 51–100 (for most of NMPs, 48%), and under 50 (22% of NMPs) (<a href="#diagnostics-12-00556-f001" class="usa-link">Figure 1</a>A). </p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/5f5fa23a431f/diagnostics-12-00556-g001.jpg" loading="lazy" height="306" width="785" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Number of patients investigated by scintigraphy for all indications, routinely each month by nuclear medicine physicians. (<strong>B</strong>) Number of patients referred each month for bisphosphonate scan and investigated by nuclear medicine physicians involved in the diagnosis of CA. NMPs-nuclear medicine physician.</p></figcaption></figure><p>The main subspecialties of nuclear medicine are represented by conventional nuclear medicine (CNM), which uses planar scintigraphic techniques or SPECT with or without hybrid techniques (SPECT/CT), in which most participants work, 94%, PET/CT in which activate 40% of the participants and the radionuclide therapy (RNT) represented by 11% of the respondents (<a href="#diagnostics-12-00556-f002" class="usa-link">Figure 2</a>A). </p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/b8ead718c015/diagnostics-12-00556-g002.jpg" loading="lazy" height="300" width="794" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Number of nuclear medicine physicians (NMPs) participating in the survey who practice the subspecialties of nuclear medicine, represented by conventional nuclear medicine (CNM), positron emission tomography with computer tomography (PET/CT) and radionuclide therapy (RNT). (<strong>B</strong>) The main types of radionuclide investigations of nuclear cardiology performed by survey participants MPS = myocardial perfusion scintigraphy, BS-CA = bisphosphonate scintigraphy for detecting cardiac amyloidosis, PET/CT = positron emission tomography with computer tomography, FP-RNV = first-pass radionuclide ventriculography, E-RNV = equilibrium radionuclide ventriculography.</p></figcaption></figure><p>Regarding the main types of nuclear cardiology imaging investigations performed, of the 34 participants who answered this question, the majority (64%) report results of myocardial perfusion scintigraphy (MPS) and just over half of them (55%) bisphosphonate scintigraphy for detecting cardiac amyloidosis (BS-CA). About a quarter of them (26%) use cardiac PET /CT mainly for the diagnosis of infective endocarditis and vasculitis. Equilibrium radionuclide ventriculography (E-RNV) and the first pass study (FP-RNV) are performed by 8% and 6%, respectively, while 11% of them perform other types of imaging investigations of nuclear cardiology (<a href="#diagnostics-12-00556-f002" class="usa-link">Figure 2</a>B).</p></section><section id="sec3dot2-diagnostics-12-00556"><h3 class="pmc_sec_title">3.2. Experience with Cardiac Amyloidosis</h3>
<p>The approximate number of scintigraphic investigations currently performed to detect cardiac amyloidosis performed in a month by survey participants is one or no investigation/month for 50% NMPs, between 2 and 4 in 44% NMPs; and only 1 participant performs more than 5 investigations/month (<a href="#diagnostics-12-00556-f001" class="usa-link">Figure 1</a>B). Most survey participants (82%) are interested in cardiac amyloidosis and have participated in conferences or courses dedicated to applications of nuclear medicine in CA. However, most of the participants (65%) are not involved in the multidisciplinary team for the diagnosis of CA in the institution where they work. </p>
<p>Nearly three-quarters of the participants (74%) found an incidental diffuse accumulation in the cardiac projection in a bisphosphonate scintigraphic investigation performed for an indication other than cardiac amyloidosis (e.g., scintigraphy performed for suspected bone metastases) (<a href="#diagnostics-12-00556-f003" class="usa-link">Figure 3</a>A). If the participants found an increased and diffuse cardiac uptake in a bisphosphonate scintigraphy investigation, they proceeded in various ways. Most participants (54%) reported abnormal cardiac uptake and interpreted it as possible CA-ATTR. However, 5% of the participants noted cardiac uptake but did not interpret it as CA. Further, it appears that they did not find it in 25%, so they did not report the existence of bisphosphonate myocardial uptake. Only 14% of participants contacted the referring physician to draw attention to the incidental findings and to send the patient to the specialized multidisciplinary team (<a href="#diagnostics-12-00556-f003" class="usa-link">Figure 3</a>B).</p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/e975fe47f6e4/diagnostics-12-00556-g003.jpg" loading="lazy" height="298" width="794" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) The number of cases of diffuse increased myocardial uptake on bisphosphonate scintigraphy with clinical indication other than CA-ATTR, incidentally encountered throughout the medical profession (MP). (<strong>B</strong>). How the survey participants reported the incidental discovery of pathological myocardial uptake on bisphosphonate scintigraphy Simple = reported, without further comment on the possible cause of CA-ATTR, Possible CA-ATTR = reported, with mention of the possible cause of myocardial uptake of bisphosphonate, +Call = possible CA-ATTR and contacted the referring doctor, Other = no diffuse increased uptake of the myocardium was observed on bisphosphonate scintigraphy in medical practice, NMPs = nuclear medicine physicians.</p></figcaption></figure></section><section id="sec3dot3-diagnostics-12-00556"><h3 class="pmc_sec_title">3.3. Cardiac Amyloidosis—Imaging Awareness</h3>
<p>Imaging tests used to diagnose patients with suspected CA at the institution where they work were considered by survey participants to be the following: echocardiography in 48% of cases, cardiac magnetic resonance imaging in 17% of cases and bisphosphonate scintigraphy in 57% of cases. There were 42% of respondents that said cardiac imaging is recommended in another medical unit (<a href="#diagnostics-12-00556-f004" class="usa-link">Figure 4</a>A). </p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f004"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/539bb6f29d6c/diagnostics-12-00556-g004.jpg" loading="lazy" height="274" width="794" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Imaging techniques used for the diagnosis of patients with CA in the respondents’ institution or in the one they work with. Cardiac US = ecocardiography, Cardiac IRM = cardiac magnetic resonance imaging, Bone Scan = bisphosphonate scintigraphy for CA detection, Other = survey participants do not work or collaborate with a cardiology department. (<strong>B</strong>) 99mTc-labeled bisphosphonated radiotracers used in CA diagnosis. HDP = hydroxyethylene diphosphonate, HMDP = hydroxymethylene diphosphonate, DPD = 2,3-dicarboxypropane-1,1-diphosphonate, PYP = sodium pyrophosphate, MDP = methylene diphosphonate, NMPs = nuclear medicine physicians.</p></figcaption></figure><p>When verifying their knowledge regarding the 99mTc-labeled bisphosphonate tracers used for detecting cardiac amyloidosis, the answers were divided as follows: 82% have chosen hydroxyethylene diphosphonate (HDP), 62% chose hydroxymethylene diphosphonate (HMDP), 42% chose 2,3-dicarboxypropane-1,1-diphosphonate (DPD), 57% chose sodium pyrophosphate (PYP), and over half of them, or 54%, chose methylene diphosphonate (MDP) (<a href="#diagnostics-12-00556-f004" class="usa-link">Figure 4</a>B).</p>
<p>The detection of myocardial uptake of 99mTc-labeled bisphosphonates on scintigraphy suggests for most participants (88%) CA with fibrillar TTR protein (CA-ATTR). However, for 3% of participants, the aspect described above suggests light chain amyloidosis (CA-AL), and for 9% of respondents, the appearance is of uncertain CA for which an additional assessment is needed to specify the type of amyloid (<a href="#diagnostics-12-00556-f005" class="usa-link">Figure 5</a>A). A score of semi-quantitative analysis (Perugini) of cardiac uptake of 99mTc-bisphosphonate refers in the opinion of participants to the degree of uptake of the radiotracer in relation to the uptake of bones for 37% of them, while for almost 63%, it represents the degree of uptake of the radiotracer in relation to the uptake of the ribs (<a href="#diagnostics-12-00556-f005" class="usa-link">Figure 5</a>B).</p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f005"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/fbc2b54aeed5/diagnostics-12-00556-g005.jpg" loading="lazy" height="315" width="780" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Interpretation of survey participants of scintigraphy in which bisphosphonates accumulate in the myocardium. CA-ATTR = cardiac amyloidosis with transthyretin, CA-AL = cardiac amyloidosis with light chains, CA? = cardiac amyloidosis of uncertain nature, No CA = the appearance is not related to cardiac amyloidosis, M = myocardium, BS = bone scan. (<strong>B</strong>) Semi-quantitative analysis score (Perugini) of cardiac uptake of 99mTc-bisphosphonate compared to uptake of the ribs, VS = visual score, Bone = VS related to bone, Ribs = VS related to ribs, NMPs = nuclear medicine physician, BS = bone scan.</p></figcaption></figure><p>Of note, the interest in creating teaching materials on systemic amyloidosis and organizing scientific events in this field is manifested in more than three quarters (77%) of participants.</p></section><section id="sec3dot4-diagnostics-12-00556"><h3 class="pmc_sec_title">3.4. Cardiac Amyloidosis in the Nuclear Medicine Laboratory </h3>
<p>The distribution of responses regarding the use of bisphosphonate radiotracers for CA detection by the responding NMPs was relatively symmetrical, with almost 49% of them giving an affirmative answer. We further report on the answers of these 18 NMPs who perform bisphosphonate scintigraphy. Among them, 50% describe the institution where they work as a reference center for amyloidosis. </p>
<p>Among these physicians, the perception regarding the clinical indications of scintigraphy for the detection of CA is the following: 66% of answering NMPs would use it for the screening of the disease, 94% for the diagnosis, 16% for the prognosis of the disease, and 22% for the evaluation of the response to therapy (<a href="#diagnostics-12-00556-f006" class="usa-link">Figure 6</a>). </p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f006"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/f7752fb2d9d8/diagnostics-12-00556-g006.jpg" loading="lazy" height="514" width="752" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Perception of bisphosphonate scintigraphy clinical indications in amyloidosis management among NMPs. NMPs = nuclear medicine physicians.</p></figcaption></figure><p>When asked about the average recommended dose for bisphosphonate scintigraphy for CA detection, the majority (77%) answered that it is in the range of 555–740 MBq (megabecquerel), and 11% considered the optimal dose between 370–554 MBq. Regarding the time interval between the administration of 99mTc-bisphosphonate and the acquisition of scintigraphy data, all participants use late data acquisition (between 1–3 h), while 38% of participants also use early acquisition (10–15 min) (<a href="#diagnostics-12-00556-f007" class="usa-link">Figure 7</a>A). The answers on the optimal time interval for the late acquisition of data have a rather varied distribution as follows: 50% consider 121–150 min, followed by those (22%) who appreciate the appropriate interval between 90–120 min, 16% apply the interval 151–180 min, and finally, 11% use the interval 60–89 min to detect the distribution of the radiotracer (<a href="#diagnostics-12-00556-f007" class="usa-link">Figure 7</a>B).</p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f007"><h4 class="obj_head">Figure 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/e18162a653cb/diagnostics-12-00556-g007.jpg" loading="lazy" height="295" width="791" alt="Figure 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Time interval between the administration of 99mTc-bisphosphonate for the early (<strong>A</strong>) and late (<strong>B</strong>) acquisition.</p></figcaption></figure><p>The imaging protocol in the scintigraphic diagnosis of CA is represented among the survey participants by the following types of acquisition: whole-body planar (94%), thoracic planar (88%), thoracic SPECT (64%) and only cardiac SPECT (5%) (<a href="#diagnostics-12-00556-f008" class="usa-link">Figure 8</a>A). </p>
<figure class="fig xbox font-sm" id="diagnostics-12-00556-f008"><h4 class="obj_head">Figure 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8870760_diagnostics-12-00556-g008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d101/8870760/7254a5a163eb/diagnostics-12-00556-g008.jpg" loading="lazy" height="293" width="794" alt="Figure 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/diagnostics-12-00556-f008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>). Image acquisition protocol, part of the imaging protocol in CA-ATTR diagnosis. Thoracic planar = Acquisition of image in the same plane in antero-posterior and oblique incidents. WB planar = Incidents in the same plane anterior and posterior whole body (vertex-soles). SPECT = Single photon-emission computed tomography at the thorax. Cardiac SPECT = Single photon-emission computed tomography only at the level of the heart. (<strong>B</strong>). Reporting the uptake of 99mTc-bisphosphonate in the myocardium.</p></figcaption></figure><p>Visual or qualitative analysis of bisphosphonate scintigraphy for describing the appearance of the radiotracer uptake at the level of the heart, such as no uptake, focal uptake, diffuse uptake, focal uptake superimposed on the diffuse one, is used by all participants (100%) involved in the imaging diagnosis of CA. Survey respondents interpret bisphosphonate scintigraphy quite differently: 23% only qualitatively, in which CA is present or absent, 11% only quantitative or semi-quantitative, through various reporting methods, and 64% use both methods in the scintigraphy interpretation (<a href="#diagnostics-12-00556-f008" class="usa-link">Figure 8</a>B). </p>
<p>In the semi-quantitative interpretation of cardiac uptake, the Perugini visual score (VS 0–3) is used by 88% of participants who currently use scintigraphy for CA detection. In the opinion of the respondents, the diagnostic significance attributed to the visual score Perugini 1 (VS 1) makes the existence of a CA-ATTR unlikely for 82% of the respondents, while being considered diagnostic for CA-AL in 17%. The quantification of the uptake of the 99mTc-bisphosphonate radiotracer from the heart, related to the contralateral region or H/CL, as part of the interpretation of the scintigraphic examination in CA, is used by over half of the participants who are involved in the diagnosis of CA (52%).</p></section></section><section id="sec4-diagnostics-12-00556"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>The present study reports the results of the first national survey conducted in Romania regarding current awareness and knowledge on CA and nuclear techniques among NMPs. Such data are sparse in the literature, even though we conducted it during a time frame when the increasing knowledge and interest regarding amyloidosis in general and CA, in particular, is driven by the emergence of diagnostic and therapeutic options for severe diseases. </p>
<p>Current evidence and a need to standardize the most effective diagnostic and therapeutic methods led to the development of “A Scientific Statement from the American Heart Association” in July 2020 [<a href="#B16-diagnostics-12-00556" class="usa-link" aria-describedby="B16-diagnostics-12-00556">16</a>] and “A Position Statement from the ESC Working Group on Myocardial and Pericardial Diseases” in April 2021 [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. Several national cardiology societies developed guidelines for the evaluations and management of CA in the last two years [<a href="#B17-diagnostics-12-00556" class="usa-link" aria-describedby="B17-diagnostics-12-00556">17</a>,<a href="#B18-diagnostics-12-00556" class="usa-link" aria-describedby="B18-diagnostics-12-00556">18</a>,<a href="#B19-diagnostics-12-00556" class="usa-link" aria-describedby="B19-diagnostics-12-00556">19</a>]. Dorbala et al. developed in December 2019 the “Expert consensus recommendations for multimodality imaging in cardiac amyloidosis” in two parts: “Evidence Base and Standardized Methods of Imaging” and “Diagnostic Criteria and Appropriate Utilization”, respectively, representing complete guidelines for current imaging practice in CA [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>,<a href="#B10-diagnostics-12-00556" class="usa-link" aria-describedby="B10-diagnostics-12-00556">10</a>], with a more recent Addendum detailing several acquisitions and reporting rules [<a href="#B20-diagnostics-12-00556" class="usa-link" aria-describedby="B20-diagnostics-12-00556">20</a>]. The Romanian Society of Nuclear Medicine and Molecular Imaging (SRMNIM) has translated in June 2021 the European Nuclear Medicine Guide—a joint publication by EANM and UEMS/EBNM, to be included in the training curriculum for physicians in training [<a href="#B21-diagnostics-12-00556" class="usa-link" aria-describedby="B21-diagnostics-12-00556">21</a>].</p>
<p>However, this first survey among Romanian NMPs primarily reflects several gaps in knowledge about the diagnostic use of BS and imaging interpretation in ATTR-CA. We believe that this varied distribution of NMPs responses is an opportunity to increase continuing medical education hours on the contribution of bisphosphonate scintigraphy in CA detection. Additionally, 77% of participants are interested in creating teaching materials and organizing scientific events related to systemic amyloidosis. Currently, in Romania, BS with bisphosphonates is by far the most used diagnostic imaging method that belongs to CNM, and this is an advantage in both screening and diagnosing patients with CA-ATTR, but also in discovering incidental cases in patients with another indication by performing BS. Several measures could assist in improving knowledge in this rare clinical condition: involving NMPs in an “amyloidosis team,” efficient reporting of CA-ATTR incidentalomas, and knowledge of diagnostic guidelines and protocols of nuclear imaging.</p>
<p>Another study related the knowledge to the diagnosis and therapy of CA among Romanian cardiologists was also conducted by Adam et al. The study’s findings highlight that the Romanian cardiologists are partially aware of CA, but several misconceptions about the diagnostic suspicion of CA and therapy, emphasize the need to update the knowledge related to this pathological condition [<a href="#B22-diagnostics-12-00556" class="usa-link" aria-describedby="B22-diagnostics-12-00556">22</a>].</p>
<section id="sec4dot1-diagnostics-12-00556"><h3 class="pmc_sec_title">4.1. Involvement of NMPs in the “Amyloidosis Team”</h3>
<p>Only 35% of the participants are involved in the nuclear diagnosis of CA-ATTR, and 44% of them perform between 2 and 4 BS per month for the diagnosis of CA. Most NMPs (65%) are not part of an “amyloidosis team” that includes at least one cardiologist, a hematologist, a neurologist, a pathologist, and a radiologist to perform cardiac MRI.</p>
<p>The concept of the amyloidosis team was presented in the recent ESC position statement on CA diagnosis and therapy, which mentioned that specific treatment in cardiac AL amyloidosis should be undertaken by multidisciplinary teams involving oncohaematology and cardiology specialists [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. While Dorbala et al. published a document on the use of multimodality imaging in CA by a panel of multidisciplinary experts, they did not refer to the need of including cardiac imaging specialists from the various techniques in a larger amyloidosis team. We know now that several particular situations exist in the use of nuclear medicine for CA. Recent studies demonstrated suboptimal sensitivity of DPD scintigraphy in patients carrying the early-onset Val50Met (formerly Val30Met) variant and other genotypes like Phe64Leu. Therefore, the accuracy of the technique may be influenced by the ATTRv genetic variant [<a href="#B23-diagnostics-12-00556" class="usa-link" aria-describedby="B23-diagnostics-12-00556">23</a>,<a href="#B24-diagnostics-12-00556" class="usa-link" aria-describedby="B24-diagnostics-12-00556">24</a>]. Moreover, a Perrugini score of 1 and even higher can be found in CA-AL, and this should be excluded using hematological tests [<a href="#B7-diagnostics-12-00556" class="usa-link" aria-describedby="B7-diagnostics-12-00556">7</a>,<a href="#B23-diagnostics-12-00556" class="usa-link" aria-describedby="B23-diagnostics-12-00556">23</a>,<a href="#B25-diagnostics-12-00556" class="usa-link" aria-describedby="B25-diagnostics-12-00556">25</a>]. Other examples reflecting the importance of a multidisciplinary amyloidosis team are echocardiography or cardiac MRI highly suggestive of CA and negative BS, BS positive and abnormal FLC (free light chain) [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>,<a href="#B25-diagnostics-12-00556" class="usa-link" aria-describedby="B25-diagnostics-12-00556">25</a>], and BS incidentaloma positive for CA-ATTR.</p>
<p>Therefore, with the current knowledge that CA is not a rare disease (especially ATTRwt) and is part of systemic involvement, the concept of amyloidosis team should be taken further because involving NMPs in a multidisciplinary expert panel during the diagnosis and follow-up of patients will enhance expertise and lead to an earlier and more precise diagnosis for the patients.</p></section><section id="sec4dot2-diagnostics-12-00556"><h3 class="pmc_sec_title">4.2. CA-ATTR Incidentalomas in Bone Scan</h3>
<p>Probably one of the situations we encounter quite often in medical imaging in general and in bisphosphonate scintigraphy with an oncological indication, in particular, is represented by incidentalomas, i.e., the accidental discovery of pathology, in this case, of CA-ATTR. Bone scintigraphy with oncological indication represents most CNM investigations in Romania, and NMPs can encounter various imaging findings, e.g., bone metabolic diseases (Paget’s disease, renal osteodystrophy with hyperparathyroidism) or the more frequent appearance of bone trauma. There is a varied experience with incidental findings in bisphosphonate scintigraphy: while 25% of the responding NMPs did not encounter in daily medical practice any case of diffuse cardiac uptake in the myocardium at a BS performed for an indication other than the suspicion of CA-ATTR, another 22% encountered more than three cases during their professional career. Of the 75% of respondents who encountered at least one case of a positive BS for CA, only 14% contacted the referring physician to draw attention to the incidental discovery, while 5% did not interpret the scintigraphy aspect as possible coexistence of CA. Given that CA-ATTR is a rare disease, with a prevalence often underestimated even by cardiologists [<a href="#B26-diagnostics-12-00556" class="usa-link" aria-describedby="B26-diagnostics-12-00556">26</a>], other specialties that refer the patient for bone scintigraphy (oncology, rheumatology, urology, surgery, etc.) could overlook such a diagnosis, with direct consequences on the possibility of treatment of the patient. If not aware of its significance, myocardial uptake during bisphosphonate scintigraphy might be overlooked without reporting the suspicion of CA-ATTR. </p></section><section id="sec4dot3-diagnostics-12-00556"><h3 class="pmc_sec_title">4.3. Significance of Cardiac Uptake and Types of Bisphosphonate Radiotracer</h3>
<p>While 88% of responders correctly link the myocardial uptake during bisphosphonate scintigraphy to CA-ATTR, more than 10% of respondents stated that the reason for myocardial uptake of 99Tc-labeled bisphosphonates could be a CA-AL or a CA with fibrillar proteins of uncertain nature that require further investigation to determine the type of amyloid. Moreover, the semi-quantitative analysis score (visual score VS Perugini) refers in the opinion of 32% of the participants to the degree of uptake of bisphosphonate in the heart in relation to bone uptake and not as specified in Dorbala et al. in the Expert Consensus Recommendation, with the one at the rib level [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>]. </p>
<p>One of the most inconsistent responses was related to the use of 99mTc-bisphosphonate types, in which more than half of the participants answered that methylene diphosphonate (MDP) could be used for CA-ATTR detection. The tracers 99mTc-MDP and 99mTc-aprotinin are not recommended for imaging cardiac amyloidosis [<a href="#B16-diagnostics-12-00556" class="usa-link" aria-describedby="B16-diagnostics-12-00556">16</a>]. Recommended radiotracers based on 99mTc-bisphosphonates for the diagnosis of ATTR amyloidosis are 99mTc-pyrophosphate (99mTc-PYP), 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) and 99mTc-hydroxymethylenediphosphonate (99mTc-HMDP) [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>].</p>
<p>Regarding the use of 99mTc-bisphosphonate BS results, 16% answered that scintigraphy has prognostic value, while 22% believe that it is useful in evaluating the response to therapy. Castano et al. highlighted in a multicenter study of planar Technetium 99m Pyrophosphate (PYP) Cardiac Imaging that a H/CL ratio of 1.6 or greater was associated with worse survival among patients with ATTR cardiac amyloidosis [<a href="#B27-diagnostics-12-00556" class="usa-link" aria-describedby="B27-diagnostics-12-00556">27</a>]. The association of 99mTc-PYP uptake with interventricular septum thickness or NYHA classes of heart failure or NT-proBNP levels improves prognostic risk stratification. Although the semi-quantitative evaluations of the H/WB ratio for 99mTc-DPD and the H/CL ratio for 99mTc-PYP could identify the increased risk for major adverse cardiac events, the visual gradient of 99mTc-HMDP/DPD did not prove to be an independent predictor of outcome [<a href="#B28-diagnostics-12-00556" class="usa-link" aria-describedby="B28-diagnostics-12-00556">28</a>]. However, monitoring CA-ATTR using nuclear techniques lacks evidence. In the recently published ESC position statement on CA [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>], Garcia-Pavia et al. stated that the value of nuclear techniques in assessing the progression of ATTR-CM is not fully elucidated, and therefore, the expert group did not make a recommendation for their use in disease monitoring.</p></section><section id="sec4dot4-diagnostics-12-00556"><h3 class="pmc_sec_title">4.4. Practical Aspect in the Nuclear Medicine Laboratory</h3>
<p>The average dose administered for 99mTc-bisphosphonate is in the range of 370–740 MBq, according to recommendations for standardized acquisition of 99mTc-PYP/DPD/HMDP for CA [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>]. More than three-quarters of our survey participants use the upper half of the reference range (555–740 MBq), while only 11% use the lower recommended doses (370–554 MBq) for an optimal diagnosis of CA. The remaining 11% do not know the recommended dose range. </p>
<p>Regarding the early acquisition of scintigraphic data, 38% of the participants, using 99mTc-bisphosphonate scintigraphy for detecting cardiac amyloidosis, gave an affirmative answer, but when asked about the time between the administration of the radiotracer and the early acquisition, the distribution of answers was quite different. These results indicate a lack of knowledge of the results obtained through the early acquisition of scintigraphic data and their use in current practice. Early whole-body counts are used to represent the injected activity. Whole-body (WB) retention is calculated by subtraction from early to late WB (corrected for disintegration and scanning speed, decreasing bladder and kidney activity). Heart retention (HR) is obtained by comparing decay-corrected counts of the heart in late images with counts in early whole-body images. The H/WB ratio refers to the heart and whole-body late counts ratio. These are semi-quantitative analyses used especially in clinical trials to accurately assess the dose administered, cardiac retention and whole-body distribution of the radiotracer [<a href="#B29-diagnostics-12-00556" class="usa-link" aria-describedby="B29-diagnostics-12-00556">29</a>].</p>
<p>According to the same consensus [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>], the late acquisition of scintigraphic data after the administration of 99mTc-bisphosphonates is performed within 1–3 h. More precisely, for 99mTc-PYP, the recommended waiting time is 1 h and optionally 3 h if there is a risk of false results (for example, the persistence of the excess radiotracer in the blood pool on the images at 1 h), while for 99mTc-HMDP/DPD recommendation is 2 or 3 h after injection of the radiotracer. Meanwhile, in August 2021, Dorbala et al. published an Addendum [<a href="#B20-diagnostics-12-00556" class="usa-link" aria-describedby="B20-diagnostics-12-00556">20</a>] to the previous consensus [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>], stating that the recommended time interval between 99mTc-PYP/DPD/HMDP injection and acquisition is 2–3 h. Optionally for 99mTc-PYP, scintigraphic data acquisition is maintained at 1-h and rescan at 3-h in case of inadequate imaging (excess blood pool noted at 1-h) Noting that in Romania, 99mTc-HDP is most largely bisphosphonate radiotracer used, of all survey participants who are involved in the diagnosis of CA by BS, we notice a varied distribution of answers, so almost 67% of them prefer late acquisitions in 2–3 h, while 22% make an intermediate acquisition (90–120 min) not specified in the consensus. Only 11% prefer to obtain scintigraphic data between 60 and 90 min. </p>
<p>Thoracic SPECT was reported to be performed by only 64% of those who perform scintigraphy to detect cardiac amyloidosis. Dorbala et al. recommended [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>] the use of SPECT acquisition for all patients in whom planar imaging is positive for the standardized acquisition of 99mTc-PYP/DPD/HMDP for cardiac amyloidosis. In the last position statement of the ESC Working Group [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>], the authors emphasize the need to perform SPECT acquisition for all patients in whom there is a risk of false-positive or negative results. In the recent Addendum [<a href="#B20-diagnostics-12-00556" class="usa-link" aria-describedby="B20-diagnostics-12-00556">20</a>], Dorbala et al. introduced cardiac SPECT as required for all patients with suspected ATTR-CA. In addition, 1-h planar imaging is no longer recommended, being replaced with 2-h or 3-h imaging for all recommended bisphosphonates (99mTc-PYP/DPD/HMDP). </p>
<p>The results of 99mTc-bisphosphonate scintigraphy for CA detection include a two-step approach: visual interpretation for the positive diagnosis of CA-ATTR and semi-quantitative grading. Nearly 65% of survey participants correctly use both approaches in assessing BS. The rest of the participants evaluate the scintigraphy either only by qualitative visual interpretation (23%) or only by semi-quantitative approach (12%). Processing of anterior planar images 2–3 h after 99mTc-PYP/DPD/HMDP administration involves choosing a circular or elliptical area to circumscribe the heart (H) to the left of the sternum, without overlapping it or the left lung. The same surface overlaps in the mirror in the contralateral region (CL), right parasternally, for the background, and the H/CL ratio is calculated as the ratio of the number of counts from the two described areas. A H/CL ≥ 1.5 on 99mTc-PYP/DPD/HMDP acquisition can distinguish with a sensitivity of 97% and a specificity of 100% CA-ATTR from that of AL amyloidosis. The exclusion of AL amyloidosis should always be done with serum/urine immunofixation and a serum-free light-chains assay in all patients with suspected amyloidosis [<a href="#B20-diagnostics-12-00556" class="usa-link" aria-describedby="B20-diagnostics-12-00556">20</a>,<a href="#B29-diagnostics-12-00556" class="usa-link" aria-describedby="B29-diagnostics-12-00556">29</a>,<a href="#B30-diagnostics-12-00556" class="usa-link" aria-describedby="B30-diagnostics-12-00556">30</a>]. </p>
<p>Regarding the diagnostic significance of the G1 visual score, for 82% of participants, the existence of a CA-ATTR is unlikely. For the remaining 18%, G1 is suggestive for the diagnosis of light chain amyloidosis. Late anterior planar images, 2–3 h after 99mTc-bisphosphonate injection, allow the assessment of relative myocardial uptake, related to ribs and uptake grading in 4 scales: G0-without myocardial uptake with normal ribs uptake, G1-myocardial uptake less than ribs uptake, G2-myocardial uptake equal to ribs uptake and G3-myocardial uptake higher than ribs with mild/absent ribs uptake. The diagnosis of CA-ATTR is consistent with a relative uptake of the radiotracer in the myocardium with G2 or G3 grading. Additionally, it is necessary to exclude systemic AL amyloidosis because in over 20% of positive scintigraphy diagnostics for CA-ATTR, cardiomyopathy with light chain fibrillar proteins may exist or coexist [<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>,<a href="#B20-diagnostics-12-00556" class="usa-link" aria-describedby="B20-diagnostics-12-00556">20</a>]. Moreover, in 40% of CA-AL patients, myocardial uptake can be found, so it always requires the exclusion of monoclonal processes [<a href="#B7-diagnostics-12-00556" class="usa-link" aria-describedby="B7-diagnostics-12-00556">7</a>,<a href="#B9-diagnostics-12-00556" class="usa-link" aria-describedby="B9-diagnostics-12-00556">9</a>,<a href="#B23-diagnostics-12-00556" class="usa-link" aria-describedby="B23-diagnostics-12-00556">23</a>]. Of those who use the semi-quantitative approach to interpret scintigraphy, the majority (88%) use visual grading (Perugini), while the H/CL ratio approach is used by 53% of participants. </p></section><section id="sec4dot5-diagnostics-12-00556"><h3 class="pmc_sec_title">4.5. Comparative Value of BS Versus Other Investigations</h3>
<p>The specificity and positive predictive value of bisphosphonate scintigraphy (99mTc-PYP/DPD/HMDP) for grade 2 or 3 myocardial uptake for ATTR-CA, in the absence of detectable monoclonal proteins in serum and urine (sIFE, uIFE and sFLC κ/λ) is 100% [<a href="#B8-diagnostics-12-00556" class="usa-link" aria-describedby="B8-diagnostics-12-00556">8</a>]. False-positive or false-negative BS results could appear in some conditions. False-positive results for ATTR-CA may occur in: AL-amyloidosis, hydroxycloquine-induced restrictive cardiomyopathy, rare variants of CA associated with chronic kidney disease (AapoAI, AApoAII, ApoAIV or Aβ2M amyloidosis) or in radiotracer persistence in the blood pool. We may encounter false-negative results for ATTR-CA in the following circumstances: rib fractures or valvular calcifications, recent myocardial infarction, genetic variants with reduced sensitivity to bisphosphonate scintigraphy (Phe64Leu [<a href="#B23-diagnostics-12-00556" class="usa-link" aria-describedby="B23-diagnostics-12-00556">23</a>], Phe84Leu, Ser97Tyr [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]), a mild form of amyloidosis or noncompliance with acquisition types for scintigraphy [<a href="#B2-diagnostics-12-00556" class="usa-link" aria-describedby="B2-diagnostics-12-00556">2</a>]. </p>
<p>There are several advantages regarding BS as compared to other diagnostic techniques such as imaging and endomyocardial biopsy. BS for CA is performed using the same tracer in which most oncological pathologies are investigated by CNM in Romania, so it is available in almost all nuclear medicine centers. The brief medical report and the aspect of the images that do not require difficult processing, represent an advantage of the simplicity of the investigation.</p>
<p>Most but not all deposits of cardiac amyloid with mutant and wild-type transthyretin are detected by bisphosphonate scintigraphy. BS for CA can detect fibrillar proteins in the myocardium before the thickening of the heart walls or reduction of voltage on the ECG [<a href="#B16-diagnostics-12-00556" class="usa-link" aria-describedby="B16-diagnostics-12-00556">16</a>]. From the same kit for the preparation of 99mTc-bisphosphonate, several bone scintigraphy investigations can be made.</p></section><section id="sec4dot6-diagnostics-12-00556"><h3 class="pmc_sec_title">4.6. The “Romanian” Variant of ATTR Glu54Gln Amyloidosis</h3>
<p>The first case of ATTRGlu54Gln amyloidosis was diagnosed in Romania in 2005 by Coriu et al. [<a href="#B31-diagnostics-12-00556" class="usa-link" aria-describedby="B31-diagnostics-12-00556">31</a>]. So far, more than 20 patients with ATTR Glu54Gln have been diagnosed, all originally from northeastern Romania, Suceava County. The prevalence of ATTRv amyloidosis in Romania is 1.02 per million (0.76 per million for the ATTR Glu54Gln mutation), and in Suceava County, it is 2.39 per 100,000 inhabitants for ATTR-Glu54Gln. The phenotype of patients with ATTRGlu54Gln amyloidosis is mixed (cardiological and neurological), and the clinical onset is in the 4th decade. Jercan et al. reported on the first 18 patients with ATTR Glu54Gln amyloidosis [<a href="#B32-diagnostics-12-00556" class="usa-link" aria-describedby="B32-diagnostics-12-00556">32</a>]. Of note, scintigraphy showed myocardial radiotracer uptake in all patients, showing high sensitivity of the technique for this mutation. This underlines the importance of improved awareness among NMPs for this diagnostic use of a widespread technique, which can save lives if recommended, performed, and reported properly.</p></section><section id="sec4dot7-diagnostics-12-00556"><h3 class="pmc_sec_title">4.7. Educational Targets</h3>
<p>Looking at the influence of the professional level as a determinant of specific knowledge, we did not find any significant differences between senior, specialist and in training NMPs, which underlines the need for continuing medical education at every step of nuclear medicine career for good usage and interpretation of this technique. Based on our findings and the issues discussed above, we propose that the continuing medical education of NMPs should be continued at all career levels and should focus on the following unmet needs. These include: (1) BS appropriateness (awareness of BS sensitivity and specificity in the positive and differential diagnosis of CA, appropriate indications of BS for CA-ATTR diagnosis); (2) knowledge of protocols (including administered doses, waiting times, recommended acquisition types, use of radiopharmaceuticals recommended in the diagnosis of CA, performing a visual analysis (qualitative) and semi-quantitative (visual score Perugini with uptake grading) in accordance with international recommendations); and (3) multidisciplinary collaboration in CA diagnosis (i.e., the need to inform the referring physician of incidental diagnoses of CA-ATTR, referring the patient to an expert center, imaging correlation with other imaging examinations as part of diagnostic management, establishing multidisciplinary teams specialized in the diagnostic and therapeutic management of the disease, participation in interdisciplinary conferences for the permanent knowledge updating).</p></section></section><section id="sec5-diagnostics-12-00556"><h2 class="pmc_sec_title">5. Study Limitation</h2>
<p>This survey-based study is small and was designed for nuclear medicine physicians in Romania. The answers of the specialists in nuclear medicine highlighted the current level of knowledge regarding CA. </p>
<p>One of the limitations of the study is the low addressability, due to the small community of nuclear medicine physicians in Romania, compared to other specialties. However, the respondents exceeded half of the Romanian nuclear physicians’ community from all three levels of training available in Romania. </p>
<p>The geographical distribution of the respondents was both from the three major university centers in the country, as well as from non-university hospitals or private medical centers. Thus, it was possible to get an overview of knowledge of nuclear medicine physicians in Romania regarding cardiac amyloidosis.</p></section><section id="sec6-diagnostics-12-00556"><h2 class="pmc_sec_title">6. Conclusions</h2>
<p>Knowledge regarding scintigraphy used for CA diagnosis among nuclear physicians in Romania remains one of the biggest challenges. Romanian nuclear physicians are partially familiar with CA diagnosis by scintigraphy, but its diagnostic potential and standardization, recommended radiotracers and acquisition times and interpretation algorithms are known in varying proportions. Therefore, there is a need to enhance knowledge through continuing medical education programs, leading to standardization of the protocols for the acquisition and accurate interpretation of bisphosphonate scintigraphy.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<section class="tw xbox font-sm" id="array1"><div class="tbl-box p" tabindex="0"><table class="content">
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AA</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with (Apo) serum amyloid A </td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AL</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with light chain </td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AApoAI</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with Apolipoprotein A I, variants</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AApoAII</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with Apolipoprotein A II, variants</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AApoAIV</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with Apolipoprotein A IV, variants</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Aβ2M</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with β2-microglobulin </td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AFib</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with Fibrinogen α, variants </td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">AGel</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with Gelasolin variants</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ATTR</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with transthyretin </td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ATTRv</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with variant transthyretin </td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ATTRwt</td>
<td align="left" valign="middle" rowspan="1" colspan="1">amyloid fibrils proteins with wild-type transthyretin</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">BS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">bone scan</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">CA</td>
<td align="left" valign="middle" rowspan="1" colspan="1">cardiac amyloidosis</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">CNM</td>
<td align="left" valign="middle" rowspan="1" colspan="1">conventional nuclear medicine</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">CMR</td>
<td align="left" valign="middle" rowspan="1" colspan="1">cardiac magnetic resonance</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ECG</td>
<td align="left" valign="middle" rowspan="1" colspan="1">electrocardiography</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">EMB</td>
<td align="left" valign="middle" rowspan="1" colspan="1">endomyocardial biopsy</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">MBq</td>
<td align="left" valign="middle" rowspan="1" colspan="1">derived unit for radioactivity</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">MRI</td>
<td align="left" valign="middle" rowspan="1" colspan="1">magnetic resonance imaging</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">NMPs</td>
<td align="left" valign="middle" rowspan="1" colspan="1">nuclear medicine physicians</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PET/CT</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Positron emission tomography/computed tomography</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">RNT</td>
<td align="left" valign="middle" rowspan="1" colspan="1">radionuclide therapy</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">SPECT</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Single photon-emission computed tomography</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">SPECT/CT</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Single photon-emission computed tomography/computed tomography</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">TTR</td>
<td align="left" valign="middle" rowspan="1" colspan="1">transthyretin</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">US</td>
<td align="left" valign="middle" rowspan="1" colspan="1">ultrasound</td>
</tr>
</table></div>
<div class="p text-right font-secondary"><a href="table/array1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="app1-diagnostics-12-00556" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The copy of the complete online questionnaire is available online at <a href="http://www.mdpi.com/article/10.3390/diagnostics12020556/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.mdpi.com/article/10.3390/diagnostics12020556/s1</a>.</p>
<section class="sm xbox font-sm" id="diagnostics-12-00556-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/8870760/bin/diagnostics-12-00556-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (121.6KB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, C.S. and R.J.; methodology, C.S. and R.J.; software, C.S. and R.J.; formal analysis, C.S. and R.J.; investigation, C.S. and R.J.; writing—original draft preparation, C.S.; writing—review and editing, C.S., R.M., R.D.A. and R.J.; visualization, C.S., R.M., R.D.A. and R.J.; supervision, R.J. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by an unrestricted educational grant from the Pfizer competitive independent research Global Medical Grants program under grant contract no 2480/14.05.2020.</p></section><section id="notes3"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Not applicable. Participation in the questionnaire was anonymous and voluntary, and participants were informed that the authors planned to publish the results, so ethical approval was not required.</p></section><section id="notes5"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data presented in this study are available on request from the corresponding author.</p></section><section id="notes6"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>R.J. reports speaker fees and unrestricted grants from Pfizer, non-competing with the present work. C.S. reports speaker fees from Pfizer, non-competing with present work. The authors report no other conflict of interest in this work.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s Note:</strong> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-diagnostics-12-00556">
<span class="label">1.</span><cite>Benson M.D., Buxbaum J.N., Eisenberg D.S., Merlini G., Saraiva M.J.M., Sekijima Y., Sipe J.D., Westermark P. Amyloid nomenclature 2020: Update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27:217–222. doi: 10.1080/13506129.2020.1835263.</cite> [<a href="https://doi.org/10.1080/13506129.2020.1835263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33100054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Amyloid%20nomenclature%202020:%20Update%20and%20recommendations%20by%20the%20International%20Society%20of%20Amyloidosis%20(ISA)%20nomenclature%20committee&amp;author=M.D.%20Benson&amp;author=J.N.%20Buxbaum&amp;author=D.S.%20Eisenberg&amp;author=G.%20Merlini&amp;author=M.J.M.%20Saraiva&amp;volume=27&amp;publication_year=2020&amp;pages=217-222&amp;pmid=33100054&amp;doi=10.1080/13506129.2020.1835263&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-diagnostics-12-00556">
<span class="label">2.</span><cite>Garcia-Pavia P., Rapezzi C., Adler Y., Arad M., Basso C., Brucato A., Burazor I., Caforio A.L.P., Damy T., Eriksson U., et al.  Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2021;42:1554–1568. doi: 10.1093/eurheartj/ehab072.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehab072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8060056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33825853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Diagnosis%20and%20treatment%20of%20cardiac%20amyloidosis:%20A%20position%20statement%20of%20the%20ESC%20Working%20Group%20on%20Myocardial%20and%20Pericardial%20Diseases&amp;author=P.%20Garcia-Pavia&amp;author=C.%20Rapezzi&amp;author=Y.%20Adler&amp;author=M.%20Arad&amp;author=C.%20Basso&amp;volume=42&amp;publication_year=2021&amp;pages=1554-1568&amp;pmid=33825853&amp;doi=10.1093/eurheartj/ehab072&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-diagnostics-12-00556">
<span class="label">3.</span><cite>Manganelli F., Fabrizi G.M., Luigetti M., Mandich P., Mazzeo A., Pareyson D. Hereditary transthyretin amyloidosis overview. Neurol. Sci. 2020;6:1–10. doi: 10.1007/s10072-020-04889-2.</cite> [<a href="https://doi.org/10.1007/s10072-020-04889-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9780126/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33188616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurol.%20Sci.&amp;title=Hereditary%20transthyretin%20amyloidosis%20overview&amp;author=F.%20Manganelli&amp;author=G.M.%20Fabrizi&amp;author=M.%20Luigetti&amp;author=P.%20Mandich&amp;author=A.%20Mazzeo&amp;volume=6&amp;publication_year=2020&amp;pages=1-10&amp;pmid=33188616&amp;doi=10.1007/s10072-020-04889-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-diagnostics-12-00556">
<span class="label">4.</span><cite>Ruberg F.L., Grogan M., Hanna M., Kelly J.W., Maurer M.S. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2019;73:2872–2891. doi: 10.1016/j.jacc.2019.04.003.</cite> [<a href="https://doi.org/10.1016/j.jacc.2019.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6724183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31171094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Coll.%20Cardiol.&amp;title=Transthyretin%20Amyloid%20Cardiomyopathy:%20JACC%20State-of-the-Art%20Review&amp;author=F.L.%20Ruberg&amp;author=M.%20Grogan&amp;author=M.%20Hanna&amp;author=J.W.%20Kelly&amp;author=M.S.%20Maurer&amp;volume=73&amp;publication_year=2019&amp;pages=2872-2891&amp;pmid=31171094&amp;doi=10.1016/j.jacc.2019.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-diagnostics-12-00556">
<span class="label">5.</span><cite>González-López E., Gallego-Delgado M., Guzzo-Merello G., de Haro-Del Moral F.J., Cobo-Marcos M., Robles C., Bornstein B., Salas C., Lara-Pezzi E., Alonso-Pulpon L., et al.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur. Heart J. 2015;36:2585–2594. doi: 10.1093/eurheartj/ehv338.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26224076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Wild-type%20transthyretin%20amyloidosis%20as%20a%20cause%20of%20heart%20failure%20with%20preserved%20ejection%20fraction&amp;author=E.%20Gonz%C3%A1lez-L%C3%B3pez&amp;author=M.%20Gallego-Delgado&amp;author=G.%20Guzzo-Merello&amp;author=F.J.%20de%20Haro-Del%20Moral&amp;author=M.%20Cobo-Marcos&amp;volume=36&amp;publication_year=2015&amp;pages=2585-2594&amp;pmid=26224076&amp;doi=10.1093/eurheartj/ehv338&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-diagnostics-12-00556">
<span class="label">6.</span><cite>Scully P.R., Patel K.P., Treibel T.A., Thornton G.D., Hughes R.K., Chadalavada S., Katsoulis M., Hartman N., Fontana M., Pugliese F., et al.  Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur. Heart J. 2020;41:2759–2767. doi: 10.1093/eurheartj/ehaa170.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehaa170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7395329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32267922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Prevalence%20and%20outcome%20of%20dual%20aortic%20stenosis%20and%20cardiac%20amyloid%20pathology%20in%20patients%20referred%20for%20transcatheter%20aortic%20valve%20implantation&amp;author=P.R.%20Scully&amp;author=K.P.%20Patel&amp;author=T.A.%20Treibel&amp;author=G.D.%20Thornton&amp;author=R.K.%20Hughes&amp;volume=41&amp;publication_year=2020&amp;pages=2759-2767&amp;pmid=32267922&amp;doi=10.1093/eurheartj/ehaa170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-diagnostics-12-00556">
<span class="label">7.</span><cite>Quarta C.C., Tinuper A.L., Milandri A., Gagliardi C., Caponeti G., Rapezzi C. A new therapy for transthyretin amyloidosis, no longer an orphan condition. Eur. Heart J. 2020;22:E125–E131. doi: 10.1093/eurheartj/suaa077.</cite> [<a href="https://doi.org/10.1093/eurheartj/suaa077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7270922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32523456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=A%20new%20therapy%20for%20transthyretin%20amyloidosis,%20no%20longer%20an%20orphan%20condition&amp;author=C.C.%20Quarta&amp;author=A.L.%20Tinuper&amp;author=A.%20Milandri&amp;author=C.%20Gagliardi&amp;author=G.%20Caponeti&amp;volume=22&amp;publication_year=2020&amp;pages=E125-E131&amp;pmid=32523456&amp;doi=10.1093/eurheartj/suaa077&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-diagnostics-12-00556">
<span class="label">8.</span><cite>Gillmore J.D., Maurer M.S., Falk R.H., Merlini G., Damy T., Dispenzieri A., Wechalekar A.D., Berk J.L., Quarta C.C., Grogan M., et al.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133:2404–2412. doi: 10.1161/CIRCULATIONAHA.116.021612.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.116.021612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27143678/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Nonbiopsy%20Diagnosis%20of%20Cardiac%20Transthyretin%20Amyloidosis&amp;author=J.D.%20Gillmore&amp;author=M.S.%20Maurer&amp;author=R.H.%20Falk&amp;author=G.%20Merlini&amp;author=T.%20Damy&amp;volume=133&amp;publication_year=2016&amp;pages=2404-2412&amp;pmid=27143678&amp;doi=10.1161/CIRCULATIONAHA.116.021612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-diagnostics-12-00556">
<span class="label">9.</span><cite>Dorbala S., Ando Y., Bokhari S., Dispenzieri A., Falk R.H., Ferrari V.A., Fontana M., Gheysens O., Gillmore J.D., Glaudemans A.W.J.M., et al.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J. Nucl. Cardiol. 2019;26:2065–2123. doi: 10.1007/s12350-019-01760-6.</cite> [<a href="https://doi.org/10.1007/s12350-019-01760-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31468376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nucl.%20Cardiol.&amp;title=ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI%20expert%20consensus%20recommendations%20for%20multimodality%20imaging%20in%20cardiac%20amyloidosis:%20Part%201%20of%202-evidence%20base%20and%20standardized%20methods%20of%20imaging&amp;author=S.%20Dorbala&amp;author=Y.%20Ando&amp;author=S.%20Bokhari&amp;author=A.%20Dispenzieri&amp;author=R.H.%20Falk&amp;volume=26&amp;publication_year=2019&amp;pages=2065-2123&amp;pmid=31468376&amp;doi=10.1007/s12350-019-01760-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-diagnostics-12-00556">
<span class="label">10.</span><cite>Dorbala S., Ando Y., Bokhari S., Dispenzieri A., Falk R.H., Ferrari V.A., Fontana M., Gheysens O., Gillmore J.D., Glaudemans A.W.J.M., et al.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl. Cardiol. 2020;27:659–673. doi: 10.1007/s12350-019-01761-5.</cite> [<a href="https://doi.org/10.1007/s12350-019-01761-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31468377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nucl.%20Cardiol.&amp;title=ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI%20expert%20consensus%20recommendations%20for%20multimodality%20imaging%20in%20cardiac%20amyloidosis:%20Part%202%20of%202-Diagnostic%20criteria%20and%20appropriate%20utilization&amp;author=S.%20Dorbala&amp;author=Y.%20Ando&amp;author=S.%20Bokhari&amp;author=A.%20Dispenzieri&amp;author=R.H.%20Falk&amp;volume=27&amp;publication_year=2020&amp;pages=659-673&amp;pmid=31468377&amp;doi=10.1007/s12350-019-01761-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-diagnostics-12-00556">
<span class="label">11.</span><cite>Giovanni P., Paola R., Tiziana B., Laura V., Gabriele S., Francesca L., Mario N., Laura O., Simona C., Simona D., et al.  Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine. Clin. Chem. 2009;55:499–504. doi: 10.1373/clinchem.2008.117143.</cite> [<a href="https://doi.org/10.1373/clinchem.2008.117143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19131635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Chem.&amp;title=Identification%20of%20Amyloidogenic%20Light%20Chains%20Requires%20the%20Combination%20of%20Serum-Free%20Light%20Chain%20Assay%20with%20Immunofixation%20of%20Serum%20and%20Urine&amp;author=P.%20Giovanni&amp;author=R.%20Paola&amp;author=B.%20Tiziana&amp;author=V.%20Laura&amp;author=S.%20Gabriele&amp;volume=55&amp;publication_year=2009&amp;pages=499-504&amp;pmid=19131635&amp;doi=10.1373/clinchem.2008.117143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-diagnostics-12-00556">
<span class="label">12.</span><cite>Maurer M.S., Schwartz J.H., Gundapaneni B., Elliott P.M., Merlini G., Waddington-Cruz M., Kristen A.V., Grogan M., Witteles R., Damy T., et al.  ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N. Engl. J. Med. 2018;379:1007–1016. doi: 10.1056/NEJMoa1805689.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=ATTR-ACT%20Study%20Investigators.%20Tafamidis%20Treatment%20for%20Patients%20with%20Transthyretin%20Amyloid%20Cardiomyopathy&amp;author=M.S.%20Maurer&amp;author=J.H.%20Schwartz&amp;author=B.%20Gundapaneni&amp;author=P.M.%20Elliott&amp;author=G.%20Merlini&amp;volume=379&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-diagnostics-12-00556">
<span class="label">13.</span><cite>Gaur P.S., Zimba O., Agarwal V., Gupta L. Reporting Survey Based Studies–A Primer for Authors. J. Korean Med. Sci. 2020;35:e398. doi: 10.3346/jkms.2020.35.e398.</cite> [<a href="https://doi.org/10.3346/jkms.2020.35.e398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7683244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33230988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Korean%20Med.%20Sci.&amp;title=Reporting%20Survey%20Based%20Studies%E2%80%93A%20Primer%20for%20Authors&amp;author=P.S.%20Gaur&amp;author=O.%20Zimba&amp;author=V.%20Agarwal&amp;author=L.%20Gupta&amp;volume=35&amp;publication_year=2020&amp;pages=e398&amp;pmid=33230988&amp;doi=10.3346/jkms.2020.35.e398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-diagnostics-12-00556">
<span class="label">14.</span><cite>Haugaa K.H., Marsan N.A., Cameli M., D’Andrea A., Dweck M.R., Carvalho R.F., Holte E., Manka R., Michalski B., Podlesnikar T., et al.  Criteria for surveys: From the European Association of Cardiovascular Imaging Scientific Initiatives Committee. Eur. Heart J. Cardiovasc. Imaging. 2019;20:963–966. doi: 10.1093/ehjci/jez193.</cite> [<a href="https://doi.org/10.1093/ehjci/jez193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31436816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.%20Cardiovasc.%20Imaging&amp;title=Criteria%20for%20surveys:%20From%20the%20European%20Association%20of%20Cardiovascular%20Imaging%20Scientific%20Initiatives%20Committee&amp;author=K.H.%20Haugaa&amp;author=N.A.%20Marsan&amp;author=M.%20Cameli&amp;author=A.%20D%E2%80%99Andrea&amp;author=M.R.%20Dweck&amp;volume=20&amp;publication_year=2019&amp;pages=963-966&amp;pmid=31436816&amp;doi=10.1093/ehjci/jez193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-diagnostics-12-00556">
<span class="label">15.</span><cite>Harb S.C., Haq M., Flood K., Guerrieri A., Passerell W., Jaber W.A., Miller E.J. National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy. J. Nucl. Cardiol. 2017;24:1094–1097. doi: 10.1007/s12350-016-0478-3.</cite> [<a href="https://doi.org/10.1007/s12350-016-0478-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27016106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nucl.%20Cardiol.&amp;title=National%20patterns%20in%20imaging%20utilization%20for%20diagnosis%20of%20cardiac%20amyloidosis:%20A%20focus%20on%20Tc99m-pyrophosphate%20scintigraphy&amp;author=S.C.%20Harb&amp;author=M.%20Haq&amp;author=K.%20Flood&amp;author=A.%20Guerrieri&amp;author=W.%20Passerell&amp;volume=24&amp;publication_year=2017&amp;pages=1094-1097&amp;pmid=27016106&amp;doi=10.1007/s12350-016-0478-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-diagnostics-12-00556">
<span class="label">16.</span><cite>Kittleson M.M., Maurer M.S., Ambardekar A.V., Bullock-Palmer R.P., Chang P.P., Eisen H.J., Nair A.P., Nativi-Nicolau J., Ruberg F.L. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement from the American Heart Association. Circulation. 2020;142:e7–e22. doi: 10.1161/CIR.0000000000000792.</cite> [<a href="https://doi.org/10.1161/CIR.0000000000000792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32476490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=American%20Heart%20Association%20Heart%20Failure%20and%20Transplantation%20Committee%20of%20the%20Council%20on%20Clinical%20Cardiology.%20Cardiac%20Amyloidosis:%20Evolving%20Diagnosis%20and%20Management:%20A%20Scientific%20Statement%20from%20the%20American%20Heart%20Association&amp;author=M.M.%20Kittleson&amp;author=M.S.%20Maurer&amp;author=A.V.%20Ambardekar&amp;author=R.P.%20Bullock-Palmer&amp;author=P.P.%20Chang&amp;volume=142&amp;publication_year=2020&amp;pages=e7-e22&amp;pmid=32476490&amp;doi=10.1161/CIR.0000000000000792&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-diagnostics-12-00556">
<span class="label">17.</span><cite>Fine N.M., Davis M.K., Anderson K., Delgado D.H., Giraldeau G., Kitchlu A., Massie R., Narayan J., Swiggum E., Venner C.P., et al.  Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement On the Evaluation and Management of Patients With Cardiac Amyloidosis. Can. J. Cardiol. 2020;36:322–334. doi: 10.1016/j.cjca.2019.12.034.</cite> [<a href="https://doi.org/10.1016/j.cjca.2019.12.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32145862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can.%20J.%20Cardiol.&amp;title=Canadian%20Cardiovascular%20Society/Canadian%20Heart%20Failure%20Society%20Joint%20Position%20Statement%20On%20the%20Evaluation%20and%20Management%20of%20Patients%20With%20Cardiac%20Amyloidosis&amp;author=N.M.%20Fine&amp;author=M.K.%20Davis&amp;author=K.%20Anderson&amp;author=D.H.%20Delgado&amp;author=G.%20Giraldeau&amp;volume=36&amp;publication_year=2020&amp;pages=322-334&amp;pmid=32145862&amp;doi=10.1016/j.cjca.2019.12.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-diagnostics-12-00556">
<span class="label">18.</span><cite>Kitaoka H., Izumi C., Izumiya Y., Inomata T., Ueda M., Kubo T., Koyama J., Sano M., Sekijima Y., Tahara N., et al.  JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ. J. 2020;84:1610–1671. doi: 10.1253/circj.CJ-20-0110.</cite> [<a href="https://doi.org/10.1253/circj.CJ-20-0110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32830187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20J.&amp;title=JCS%202020%20Guideline%20on%20Diagnosis%20and%20Treatment%20of%20Cardiac%20Amyloidosis&amp;author=H.%20Kitaoka&amp;author=C.%20Izumi&amp;author=Y.%20Izumiya&amp;author=T.%20Inomata&amp;author=M.%20Ueda&amp;volume=84&amp;publication_year=2020&amp;pages=1610-1671&amp;pmid=32830187&amp;doi=10.1253/circj.CJ-20-0110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-diagnostics-12-00556">
<span class="label">19.</span><cite>Yilmaz A., Bauersachs J., Bengel F., Büchel R., Kindermann I., Klingel K., Knebel F., Meder B., Morbach C., Nagel E., et al.  Diagnosis and treatment of cardiac amyloidosis: Position statement of the German Cardiac Society (DGK) Clin. Res. Cardiol. 2021;110:479–506. doi: 10.1007/s00392-020-01799-3.</cite> [<a href="https://doi.org/10.1007/s00392-020-01799-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8055575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33459839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Res.%20Cardiol.&amp;title=Diagnosis%20and%20treatment%20of%20cardiac%20amyloidosis:%20Position%20statement%20of%20the%20German%20Cardiac%20Society%20(DGK)&amp;author=A.%20Yilmaz&amp;author=J.%20Bauersachs&amp;author=F.%20Bengel&amp;author=R.%20B%C3%BCchel&amp;author=I.%20Kindermann&amp;volume=110&amp;publication_year=2021&amp;pages=479-506&amp;pmid=33459839&amp;doi=10.1007/s00392-020-01799-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-diagnostics-12-00556">
<span class="label">20.</span><cite>Dorbala S., Ando Y., Bokhari S., Dispenzieri A., Falk R.H., Ferrari V.A., Fontana M., Gheysens O., Gillmore J.D., Glaudemans A.W.J.M., et al.  Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J. Nucl. Cardiol. 2021;28:1769–1774. doi: 10.1007/s12350-020-02455-z.</cite> [<a href="https://doi.org/10.1007/s12350-020-02455-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34196911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nucl.%20Cardiol.&amp;title=Addendum%20to%20ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI%20expert%20consensus%20recommendations%20for%20multimodality%20imaging%20in%20cardiac%20amyloidosis:%20Part%201%20of%202-evidence%20base%20and%20standardized%20methods%20of%20imaging&amp;author=S.%20Dorbala&amp;author=Y.%20Ando&amp;author=S.%20Bokhari&amp;author=A.%20Dispenzieri&amp;author=R.H.%20Falk&amp;volume=28&amp;publication_year=2021&amp;pages=1769-1774&amp;pmid=34196911&amp;doi=10.1007/s12350-020-02455-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-diagnostics-12-00556">
<span class="label">21.</span><cite>Castellucci P., Deandreis D., Krizsán Á.K., Mirzaei S., Prior J., Sattler B. European Nuclear Medicine Guide, a Joint Publication by EANM and UEMS/EBNM. 2020.  [(accessed on 26 December 2021)].  Available online:  <a href="https://www.nucmed-guide.app/#!/home" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nucmed-guide.app/#!/home</a>.</cite>
</li>
<li id="B22-diagnostics-12-00556">
<span class="label">22.</span><cite>Adam R., Neculae G., Stan C., Jurcut R. Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists. Diagnostics. 2021;11:834.  doi: 10.3390/diagnostics11050834.</cite> [<a href="https://doi.org/10.3390/diagnostics11050834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8148147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34066384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics&amp;title=Current%20Challenges%20of%20Cardiac%20Amyloidosis%20Awareness%20among%20Romanian%20Cardiologists&amp;author=R.%20Adam&amp;author=G.%20Neculae&amp;author=C.%20Stan&amp;author=R.%20Jurcut&amp;volume=11&amp;publication_year=2021&amp;pages=834&amp;pmid=34066384&amp;doi=10.3390/diagnostics11050834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-diagnostics-12-00556">
<span class="label">23.</span><cite>Musumeci M.B., Cappelli F., Russo D., Tini G., Canepa M., Milandri A., Bonfiglioli R., Di Bella G., My F., Luigetti M., et al.  Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. JACC Cardiovasc. Imaging. 2020;13:1314–1321. doi: 10.1016/j.jcmg.2019.10.015.</cite> [<a href="https://doi.org/10.1016/j.jcmg.2019.10.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31864976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Cardiovasc.%20Imaging&amp;title=Low%20Sensitivity%20of%20Bone%20Scintigraphy%20in%20Detecting%20Phe64Leu%20Mutation-Related%20Transthyretin%20Cardiac%20Amyloidosis&amp;author=M.B.%20Musumeci&amp;author=F.%20Cappelli&amp;author=D.%20Russo&amp;author=G.%20Tini&amp;author=M.%20Canepa&amp;volume=13&amp;publication_year=2020&amp;pages=1314-1321&amp;pmid=31864976&amp;doi=10.1016/j.jcmg.2019.10.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-diagnostics-12-00556">
<span class="label">24.</span><cite>Azevedo Coutinho M.C., Cortez-Dias N., Cantinho G., Goncalves S., Menezes M.N., Guimaraes T., Lima da Silva G., Francisco A.R., Agostinho J., Santos L., et al.  The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease. Amyloid. 2020;27:174–183. doi: 10.1080/13506129.2020.1744553.</cite> [<a href="https://doi.org/10.1080/13506129.2020.1744553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32482106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=The%20sensitivity%20of%20DPD%20scintigraphy%20to%20detect%20transthyretin%20cardiac%20amyloidosis%20in%20V30M%20mutation%20depends%20on%20the%20phenotypic%20expression%20of%20the%20disease&amp;author=M.C.%20Azevedo%20Coutinho&amp;author=N.%20Cortez-Dias&amp;author=G.%20Cantinho&amp;author=S.%20Goncalves&amp;author=M.N.%20Menezes&amp;volume=27&amp;publication_year=2020&amp;pages=174-183&amp;pmid=32482106&amp;doi=10.1080/13506129.2020.1744553&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-diagnostics-12-00556">
<span class="label">25.</span><cite>Jurcuţ R., Onciul S., Adam R., Stan C., Coriu D., Rapezzi C., Popescu B.A. Multimodality imaging in cardiac amyloidosis: A primer for cardiologists. Eur. Heart J. Cardiovasc. Imaging. 2020;21:833–844. doi: 10.1093/ehjci/jeaa063.</cite> [<a href="https://doi.org/10.1093/ehjci/jeaa063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32393965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.%20Cardiovasc.%20Imaging&amp;title=Multimodality%20imaging%20in%20cardiac%20amyloidosis:%20A%20primer%20for%20cardiologists&amp;author=R.%20Jurcu%C5%A3&amp;author=S.%20Onciul&amp;author=R.%20Adam&amp;author=C.%20Stan&amp;author=D.%20Coriu&amp;volume=21&amp;publication_year=2020&amp;pages=833-844&amp;pmid=32393965&amp;doi=10.1093/ehjci/jeaa063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-diagnostics-12-00556">
<span class="label">26.</span><cite>Porcari A., Falco L., Lio V., Merlo M., Fabris E., Bussani R., Sinagra G. Cardiac amyloidosis: Do not forget to look for it. Eur. Heart J. 2020;22((Suppl. E)):E142–E147. doi: 10.1093/eurheartj/suaa080.</cite> [<a href="https://doi.org/10.1093/eurheartj/suaa080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7270903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32523459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Cardiac%20amyloidosis:%20Do%20not%20forget%20to%20look%20for%20it&amp;author=A.%20Porcari&amp;author=L.%20Falco&amp;author=V.%20Lio&amp;author=M.%20Merlo&amp;author=E.%20Fabris&amp;volume=22&amp;issue=(Suppl.%20E)&amp;publication_year=2020&amp;pages=E142-E147&amp;pmid=32523459&amp;doi=10.1093/eurheartj/suaa080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-diagnostics-12-00556">
<span class="label">27.</span><cite>Castano A., Haq M., Narotsky D.L., Goldsmith J., Weinberg R.L., Morgenstern R., Pozniakoff T., Ruberg F.L., Miller E.J., Berk J.L., et al.  Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients with ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016;1:880–889. doi: 10.1001/jamacardio.2016.2839.</cite> [<a href="https://doi.org/10.1001/jamacardio.2016.2839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27557400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Cardiol.&amp;title=Multicenter%20Study%20of%20Planar%20Technetium%2099m%20Pyrophosphate%20Cardiac%20Imaging:%20Predicting%20Survival%20for%20Patients%20with%20ATTR%20Cardiac%20Amyloidosis&amp;author=A.%20Castano&amp;author=M.%20Haq&amp;author=D.L.%20Narotsky&amp;author=J.%20Goldsmith&amp;author=R.L.%20Weinberg&amp;volume=1&amp;publication_year=2016&amp;pages=880-889&amp;pmid=27557400&amp;doi=10.1001/jamacardio.2016.2839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-diagnostics-12-00556">
<span class="label">28.</span><cite>Singh V., Falk R., Di Carli M.F., Kijewski M., Rapezzi C., Dorbala S. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J. Nucl. Cardiol. 2019;26:158–173. doi: 10.1007/s12350-018-01552-4.</cite> [<a href="https://doi.org/10.1007/s12350-018-01552-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6541031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30569412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nucl.%20Cardiol.&amp;title=State-of-the-art%20radionuclide%20imaging%20in%20cardiac%20transthyretin%20amyloidosis&amp;author=V.%20Singh&amp;author=R.%20Falk&amp;author=M.F.%20Di%20Carli&amp;author=M.%20Kijewski&amp;author=C.%20Rapezzi&amp;volume=26&amp;publication_year=2019&amp;pages=158-173&amp;pmid=30569412&amp;doi=10.1007/s12350-018-01552-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-diagnostics-12-00556">
<span class="label">29.</span><cite>Rapezzi C., Quarta C.C., Guidalotti P.L., Pettinato C., Fanti S., Leone O., Ferlini A., Longhi S., Lorenzini M., Reggiani L.B., et al.  Role of (99 m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc. Imaging. 2011;4:659–670. doi: 10.1016/j.jcmg.2011.03.016.</cite> [<a href="https://doi.org/10.1016/j.jcmg.2011.03.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21679902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Cardiovasc.%20Imaging&amp;title=Role%20of%20(99%20m)Tc-DPD%20scintigraphy%20in%20diagnosis%20and%20prognosis%20of%20hereditary%20transthyretin-related%20cardiac%20amyloidosis&amp;author=C.%20Rapezzi&amp;author=C.C.%20Quarta&amp;author=P.L.%20Guidalotti&amp;author=C.%20Pettinato&amp;author=S.%20Fanti&amp;volume=4&amp;publication_year=2011&amp;pages=659-670&amp;pmid=21679902&amp;doi=10.1016/j.jcmg.2011.03.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-diagnostics-12-00556">
<span class="label">30.</span><cite>Bokhari S., Castano A., Pozniakoff T., Deslisle S., Latif F., Maurer M.S. (99 m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ. Cardiovasc. Imaging. 2013;6:195–201. doi: 10.1161/CIRCIMAGING.112.000132.</cite> [<a href="https://doi.org/10.1161/CIRCIMAGING.112.000132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3727049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23400849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Cardiovasc.%20Imaging&amp;title=(99%20m)Tc-pyrophosphate%20scintigraphy%20for%20differentiating%20light-chain%20cardiac%20amyloidosis%20from%20the%20transthyretin-related%20familial%20and%20senile%20cardiac%20amyloidoses&amp;author=S.%20Bokhari&amp;author=A.%20Castano&amp;author=T.%20Pozniakoff&amp;author=S.%20Deslisle&amp;author=F.%20Latif&amp;volume=6&amp;publication_year=2013&amp;pages=195-201&amp;pmid=23400849&amp;doi=10.1161/CIRCIMAGING.112.000132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-diagnostics-12-00556">
<span class="label">31.</span><cite>Coriu D., Ailenei C., Talmaci R., Badelita S., Dobrea C., Murphy C.L., Kestler D., Solomon A. New transthyretin variant Glu54Gln associated with familial amyloidosis; Proceedings of the XIIIth Int Symposium Amyloidosis; Groningen, The Netherlands. 6–10 May 2012; pp. 357–360.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20XIIIth%20Int%20Symposium%20Amyloidosis&amp;title=New%20transthyretin%20variant%20Glu54Gln%20associated%20with%20familial%20amyloidosis&amp;author=D.%20Coriu&amp;author=C.%20Ailenei&amp;author=R.%20Talmaci&amp;author=S.%20Badelita&amp;author=C.%20Dobrea&amp;pages=357-360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-diagnostics-12-00556">
<span class="label">32.</span><cite>Jercan A., Ene A., Jurcut R., Draghici M., Badelita S., Dragomir M., Dobrea C., Popescu M., Jardan D., Stoica E., et al.  Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet J. Rare Dis. 2020;15:34. doi: 10.1186/s13023-020-1309-9.</cite> [<a href="https://doi.org/10.1186/s13023-020-1309-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6993313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32000831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J.%20Rare%20Dis.&amp;title=Clinical%20characteristics%20in%20patients%20with%20hereditary%20amyloidosis%20with%20Glu54Gln%20transthyretin%20identified%20in%20the%20Romanian%20population&amp;author=A.%20Jercan&amp;author=A.%20Ene&amp;author=R.%20Jurcut&amp;author=M.%20Draghici&amp;author=S.%20Badelita&amp;volume=15&amp;publication_year=2020&amp;pages=34&amp;pmid=32000831&amp;doi=10.1186/s13023-020-1309-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8870760/bin/diagnostics-12-00556-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (121.6KB, zip) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data presented in this study are available on request from the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Diagnostics are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/diagnostics12020556"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/diagnostics-12-00556.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8870760/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8870760/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8870760%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8870760/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8870760/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8870760/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35204645/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8870760/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35204645/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8870760/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8870760/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="7EuOZ41f6diLDPh1BOI7zfCm320hYbZ08nhvsPpr3zxhXiAmP2NNnT4WOQgRBLGE">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
